Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sciensus
Switzerlandsciensus.com ↗
- Ownership
- Private
- Employees
- ~700
- Development stage
- Commercial
01
Overview
Sciensus provides integrated patient access, engagement, logistics, real-world evidence generation, early access programs, decentralized trial support and homecare services to accelerate the development journey and maximize product value for biopharma clients in Europe. They do not conduct their own clinical trials or report clinical results as a sponsor.
- Therapeutic areas
- OncologyRare DiseasesOther
- Modalities
- Small moleculeBiologicOncology drugsRare disease therapies
- Industry
- Contract Research Organization
02
Partnerships
Works with over “50 pharma companies globally,” including partnerships with biopharma firms launching new medicines in Europe.Collaborates with CROs/CCOs on decentralized trials and early access programs.
Beyond the preview
Go deeper on Sciensus.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sciensus.